Adagene

📍 Suzhou Industrial Park,, China🗓 Founded 2012👥 87 employees💰 Last funded 2020
Biotechnology Research🌐 adagene.com
Website LinkedIn
Adagene Inc. (Nasdaq: ADAG) is a biotechnology company transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Powered by its proprietary DPL platform, composed of NEObody, SAFEbody™, and POWERbody™ technologies, Adagene’s highly differentiated pipeline features novel immunotherapy programs. Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2012
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Adagene?
Adagene has 1 investors on record on gritt.io and 1 late-stage investors.
When did Adagene last raise funding?
The most recent investment in Adagene recorded on gritt.io was in 2020.
When was Adagene founded?
Adagene was founded in 2012.
What industry is Adagene in?
Adagene operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Adagene based?
Adagene is headquartered in Suzhou Industrial Park,, China.